Piperacillin therapy for complicated urinary tract infections caused by enterococci alone and in association with multi-drug resistant pathogens
Gesu, G.P.; Manca, E.; Pompei, R.; Stefani, S.; Zedda, M.S.; Russo, G.; Satta, G.; Schito, G.C.
Chemioterapia international journal of the Mediterranean Society of Chemotherapy 6(2 Suppl): 508-510
1987
ISSN/ISBN: 0392-906X PMID: 3334611 Document Number: 303073
Document emailed within 1 workday
Related Documents
Ueno, M.; Ikeuchi, T.; Kai, Y. 1988: Reevaluation of clinical efficacy of piperacillin against complicated urinary tract infections Hinyokika Kiyo. Acta Urologica Japonica 34(9): 1675-1678Biechteler, W.; Haas, F. 1971: Enterococci-induced urinary tract infections Medizinische Klinik 66(45): 1522-1525
Vignesh, R.; Shankar, E.M.; Murugavel, K.G.; Kumarasamy, N.; Sekar, R.; Irene, P.; Solomon, S.; Balakrishnan, P. 2008: Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India NEPHRON. Clinical Practice 110(1): C55-C57
Datta, S.; Wattal, C.; Goel, N.; Oberoi, J.K.; Raveendran, R.; Prasad, K.J. 2012: A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital Indian Journal of Medical Research 135(6): 907-912
Haschek, H. 1972: Drug therapy of chronic urinary tract infections Die Medizinische Welt 23(42): 1473-1475
Fujimura, N.; Yuasa, K.; Uema, K.; Kurokawa, K. 1984: Clinical studies on combination therapy of cephem antibiotics in chronic complicated urinary tract polymicrobial infections due to Pseudomonas aeruginosa and other bacteria Japanese Journal of Antibiotics 37(9): 1669-1678
Wijting, I.E.A.; Alsma, J.; Melles, D.C.; Schipper, E.M.; Schuit, S.C.E. 2019: Urinary tract infections in a university hospital: pathogens and antibiotic susceptibility Netherlands Journal of Medicine 77(6): 210-219
Shao, H.-F.; Wang, W.-P.; Zhang, X.-W.; Li, Z.-D. 2003: Distribution and resistance trends of pathogens from urinary tract infections and impact on management Zhonghua Nan Ke Xue 9(9): 690
García Victor, F.; Ferrero Doria, R. 2001: Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension Archivos Espanoles de Urologia 54(4): 313-320
Bhowmik, D.; Singh, S. 2013: Complicated urinary tract infections Journal of the Indian Medical Association 111(8): 545-549
Watanabe, A. 2003: Hospital infection caused by multi-drug-resistant Mycobacterium tuberculosis Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 3): 117-121
Wolfhagen, M.J.; Hoepelman, I.M.; de Melker, R.A.; Verhoef, J. 1988: Diagnosis of uncomplicated urinary tract infections: complicated? Nederlands Tijdschrift Voor Geneeskunde 132(9): 390-394
Minami, Y.; Kanda, S.; Matsuo, R.; Sakai, H.; Kamemoto, H.; Hisamatsu, A.; Maruta, N.; Johdai, A.; Shimomae, H.; Watanabe, Y. 1985: Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections Hinyokika Kiyo. Acta Urologica Japonica 31(6): 1077-1084
Mizutani, S.; Nishimura, K.; Yoshimura, K.; Miyoshi, S.; Iwao, N.; Higashimoto, J.; Shiota, K. 1990: Clinical experience with ceftibuten in complicated urinary tract infections Japanese Journal of Antibiotics 43(5): 779-789
Yamakawa, K.; Hioki, T.; Kawamura, J. 1989: Clinical studies on ceftriaxone in complicated urinary tract infections Hinyokika Kiyo. Acta Urologica Japonica 35(2): 377-382
Landau, Z.; Feld, S.; Krupsky, M. 1990: Ceftriaxone or combined cefazolin-gentamicin for complicated urinary tract infections Harefuah 118(3): 152-153
Murase, T.; Mitsuya, H.; Fukatsu, H.; Yoshida, K.; Natsume, H.; Obata, K.; Ohshima, S.; Asaka, H.; Kobayashi, M.; Okamura, K. 1986: Clinical study of NFLX (norfloxacin) in complicated urinary tract infections Hinyokika Kiyo. Acta Urologica Japonica 32(8): 1167-1175
Yoshida, K.; Uchijima, Y.; Kobayashi, N.; Suwata, J.; Nakame, Y.; Saitoh, H.; Negishi, T.; Yamada, T.; Kageyama, Y.; Kura, N. 1988: Clinical efficacy of aztreonam in patients with complicated urinary tract infections Hinyokika Kiyo. Acta Urologica Japonica 34(12): 2225-2232
Place, C. 1981: An open, multi-centre evaluation of a 5-day course of pivmecillinam in urinary tract infections in general practice Pharmatherapeutica 3(1): 55-60
Cox, C.E. 1993: Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections American Journal of Medicine 94(3a): 118s-125s